Sugi Predict

Sugi Predict / Compounds / SCHEMBL10194974

SCHEMBL10194974

SCHEMBL10194974

COC1CCN(C(=O)c2ccc(-n3cc(-c4n[nH]c5ccccc45)nn3)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.45
▸ TDO2 P48775 1/20 0.45
▸ HPGD P15428 2/20 0.44
▸ MAPK10 P53779 6/20 0.43
▸ MAPK8 P45983 3/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ FLT3 P36888 6/20 0.41
▸ LMNA P02545 1/20 0.40
▸ BMPR1B O00238 1/20 0.40
▸ PLK4 O00444 1/20 0.40
▸ STK25 O00506 1/20 0.40
▸ CIT O14578 1/20 0.40
▸ RIOK3 O14730 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ GAK O14976 1/20 0.40
▸ DCLK1 O15075 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9953219 0.90 MGLL (0.44) MAPK10MAPK8MGLLALDH1A1MAPT
SCHEMBL10195710 0.89 MGLL (0.45) HPGDMAPK10MAPK8MGLLALDH1A1
SCHEMBL10195384 0.89 MAPK10 (0.40) HPGDMAPK10MAPK8ALDH1A1MAPT
SCHEMBL10194945 0.88 L3MBTL3 (0.49) HPGDMAPK10MAPK8MGLLALDH1A1
SCHEMBL10194782 0.87 MAPK10 (0.53) HPGDMAPK10MAPK8ALDH1A1MAPT
SCHEMBL10195546 0.87 MAPK10 (0.43) MAPK10MAPK8MGLLALDH1A1MAPT
SCHEMBL10195696 0.87 FLT3 (0.50) MAPK10MAPK8ALDH1A1MAPTFLT3
SCHEMBL9951947 0.86 MAPK10 (0.41) MAPK10MAPK8MGLLALDH1A1MAPT
SCHEMBL10195701 0.86 FLT3 (0.53) HPGDMAPK10MAPK8ALDH1A1MAPT
SCHEMBL10195582 0.86 L3MBTL3 (0.49) MAPK10ALDH1A1ABL1FGFR1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655357-B1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO SA (CH) 2016-06-22 — — EP disclosed
EP-2655357-B1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO SA (CH) 2016-06-22 — — EP disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 — — US disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 — — US disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 — — US disclosed
CN-103429585-A Indazolyl triazole derivatives as interleukin-1 receptor associated kinase inhibitors MERCK SERONO SA 2013-12-04 — — CN disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 — — US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 — — US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 — — US disclosed
WO-2012084704-A1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO S.A. (CH) 2012-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES NFATC1, IL5, CD4 IDO1 96/4885TDO2 2415/4885HPGD 1495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.